Detecção das metaloproteinases-2 e -9 no plexo coróide e no liquor de cães naturalmente infectados por Leishmania chagasi

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Obtenção de hibridos lapdesf fur-fd e atividade anti-inflamatória com potencial atividade neuroprotetora

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Síntese, atividade antibacteriana e farmacocinética pré-clínica de pró-fármaco do etambutol com potencial terapêutico para meningite tuberculosa

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação neurocomportamental da exposição crônica ao Mercúrio inorgânico na memória social e memória emocional de ratos wistar machos adultos

O mercúrio inorgânico é facilmente absorvido por ingestão ou via cutânea. Entretanto, uma quantidade relativamente pequena de Hg²⁺ atravessa a barreira hematoencefálica ou as membranas biológicas, sendo em ratos adultos, o transporte axonal retrógrado a única via para a absorção de Hg²⁺ por neurônios, apresentando um forte potencial neurotóxico. Desta forma, o presente estudo objetivou investigar os efeitos da exposição crônica ao cloreto de mercúrio em memória social e emocional de ratos adultos. Para isso utilizou-se ratos Wistar, machos (n=40), com 5 meses de idade, distribuídos em dois grupos, um dos quais foi exposto ao Cloreto de Mercúrio (HgCl₂) via oral, por gavagem intra-gástrica (0,375mg/Kg), durante 45 dias. O outro grupo, denominado grupo controle (n=20) recebeu água destilada por gavagem. Foram utilizados os seguintes testes comportamentais: teste do campo aberto, teste de reconhecimento social para avaliação de memória social; o Teste do Labirinto em T Elevado (LTE) foi usado para avaliar o aprendizado do estado de esquiva e as memórias de curta e longa-duração. Após a finalização dos testes, os animais foram sacrificados para a dosagem do mercúrio total no hipocampo e através de um Espectrofotômetro de Absorção Atômica. Os resultados revelaram que os animais submetidos à exposição ao cloreto de mercúrio não manifestaram déficits em atividade exploratória. Nos dados do Teste de Reconhecimento Social, observamos que não houve alteração em memória social. No teste do LTE, o grupo exposto ao HgCl₂ necessitou de um número maior de exposições para aquisição do critério de esquiva (p<0,05) e apresentaram latência maior no braço aberto do aparato (p<0,05). Após 24 horas, verificou-se que os animais expostos passaram menos tempo no braço fechado em relação ao grupo controle, sugerindo déficits de memória de longa duração. Ao observar apenas o grupo HgCl₂, percebeu-se uma melhora no reteste, indicando preservação na memória de curta duração. Os dados de espectrometria de absorção atômica mostraram uma maior deposição de mercúrio no hipocampo de animais intoxicados, em relação aos animais do grupo controle.

Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs

The treatment of central nervous system (CNS) diseases is a major challenge. The presence of the barrier intended to protect the brain from unwanted molecules also impairs the efficacy of CNS-targeted drugs. The discovery of drug targets for CNS diseases opens a door for the selective treatment of these diseases. However, the physicochemical properties of drugs, including their hydrophilic properties and their peripheral metabolism, as well as the blood-brain barrier, can adversely affect the therapeutic potential of CNS-targeted drugs. Although peptides are often metabolized by enzymes, they are of particular interest for the treatment of CNS diseases or as carriers to deliver drugs to the brain. In this review, we discuss the use of peptides as potential prodrugs for the treatment of CNS diseases.

Leptomeningeal enhancement in computed tomography of feline brains

Contrast enhancement enables the verification of several pathological conditions that lead to vascular changes and/or breakdown of the blood-brain barrier. Examples of diseases that cause these disorders are: neoplastic diseases, vascular communications, active inflammation and cerebral ischemia. Several contrast enhancements located peripherically to cerebral lobes, in the topography of brain sulci and gyri, were identified on tomographic scan of twelve healthy cats that had their health confirmed through history, general and neurologic physical examination and polymerase chain reaction for feline leukemia (FeLV) and immunodeficiency (FIV) virus. This study aims to describe the tomographic contrast enhancement findings, which showed an identical appearance to the pia mater and arachnoid enhancement, also called leptomeninges. This finding is generally considered related to leptomeningeal diseases such as meningitis and neoplastic disease. However, in dogs, the leptomeningeal enhancement has already been described in healthy animals. This finding has a great importance in the interpretation of tomographic images of these animals since, so far, in the presence of these enhancements, meningeal disorders were suggested. Thus, the verification of other tomographic findings and the combination with other diagnostic methods are of great importance for the diagnosis of leptomeningeal disease.

Metaloproteinases de matriz 2 e 9 no líquido cefalorraquidiano e soro de cães naturalmente infectados pelo vírus da cinomose

Pós-graduação em Medicina Veterinária - FCAV

Imunofenótipos de linfócitos T no sangue e no liquor de cães com leishmaniose visceral: correlação com as lesões encefálicas

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease

Alzheimer's disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood-brain barrier. Nanotechnological treatment methods, which involve the design, characterization, production, and application of nanoscale drug delivery systems, have been employed to optimize therapeutics. These nanotechnologies include polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, microemulsion, nanoemulsion, and liquid crystals. Each of these are promising tools for the delivery of therapeutic devices to the brain via various routes of administration, particularly the intranasal route. The objective of this study is to present a systematic review of nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Leishmaniose visceral e o sistema nervoso central: inflamação nas infecções natural canina e experimental em camundongos: Guilherme Dias de Melo. -

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Vascular dementia

The epidemic growth of dementia causes great concern for the society. It is customary to consider Alzheimer's disease (AD) as the most common cause of dementia, followed by vascular dementia (VaD). This dichotomous view of a neurodegenerative disease as opposed to brain damage caused by extrinsic factors led to separate lines of research in these two entities. Indeed, accumulated data suggest that the two disorders have additive effects and probably interact; however it is still unknown to what degree. Furthermore, epidemiological studies have shown "vascular" risk factors to be associated with AD. Therefore, a clear distinction between AD and VaD cannot be made in most cases, and is furthermore unhelpful. In the absence of efficacious treatment for the neurodegenerative process, special attention must be given to the vascular component, even in patients with presumed mixed pathology. Symptomatic treatment of VaD and AD is similar, although the former is less effective. For prevention of dementia it is important to treat all factors aggressively, even in stroke survivors who do not show evidence of cognitive decline. In this review, we will give a clinical and pathological picture of the processes leading to VaD and discuss its interaction with AD. (c) 2012 Elsevier B.V. All rights reserved.

Cerebral amyloid angiopathy impact on endothelium

Cerebral amyloid angiopathy (CAA) is an age-associated disease characterized by amyloid deposition in cerebral and meningeal vessel walls. CAA is detected in the majority of the individuals with dementia and also in a large number of non-demented elderly individuals. In addition, CAA is strongly associated with Alzheimer's disease (AD) pathology. Mechanical consequences including intra-cerebral or subarachnoid hemorrhage remains CAA most feared complication, but only a small fraction of CAA results in severe bleeding. On the hand the non-mechanical consequences in cerebrovascular regulation are prevalent and may be even more deleterious. Studies of animal models have provided strong evidence linking the vasoactive A beta 1-40, the main species found in CAA, to disturbances in endothelial-dependent factors, disrupting cerebrovascular regulation Here, we aimed to review experimental findings regarding the non-mechanical consequences of CAA for cerebrovascular regulation and discuss the implications of these results to clinical practice. (C) 2012 Elsevier Inc. All rights reserved.

Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine

We investigated whether three relevant polymorphisms (C-1562T, microsatellite - 90(CA)(14-24), and Q279R) in the MMP-9 gene, or MMP-9 haplotypes, are associated with migraine and affect MMP-9 and tissue inhibitor of MMPs (TIMP)-1 levels in patients with migraine. We studied 102 healthy women (controls) and 187 women with migraine (141 without aura - MWA, and 46 with aura - MA). Patients with MWA had higher plasma MMP-9 concentrations than patients with MA. Patients with MA had the highest TIMP-1 and lowest MMP-9/TIMP-1 ratios. The MMP-9 "C L Q" haplotype was associated with higher plasma MMP-9 concentrations in migraine patients. (C) 2012 Elsevier B.V. All rights reserved.

New molecular targets for PET and SPECT imaging in neurodegenerative diseases

The pathophysiology of neurodegenerative diseases (ND) such as Alzheimer's disease (AD) and Parkinson's disease (PD) has not yet been completely elucidated. However, in the past few years, there have been great knowledge advances about intra-and extracellular proteins that may display impaired function or expression in AD, PD and other ND, such as amyloid beta (AB), alpha-synuclein, tau protein and neuroinfiammatory markers. Recent developments in the imaging techniques of positron emission tomography (PET) and single photon emission computed tomography (SPECT) now allow the non-invasive tracking of such molecular targets of known relevance to ND in vivo. This article summarizes recent findings of PET and SPECT studies using these novel methods, and discusses their potential role in the field of drug development for ND as well as future clinical applications in regard to differential diagnosis of ND and monitoring of disease progression.

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis

Pneumococcal meningitis is a life-threatening disease characterized by an acute infection affecting the pia matter, arachnoid and subarachnoid space. The intense inflammatory response is associated with a significant mortality rate and neurologic sequelae, such as, seizures, sensory-motor deficits and impairment of learning and memory. The aim of this study was to evaluate the effects of acute and extended administration of cannabidiol on pro-inflammatory cytokines and behavioral parameters in adult Wistar rats submitted to pneumococcal meningitis. Male Wistar rats underwent a cisterna magna tap and received either 10 mu l of sterile saline as a placebo or an equivalent volume of S. pneumoniae suspension. Rats subjected to meningitis were treated by intraperitoneal injection with cannabidiol (2.5, 5, or 10 mg/kg once or daily for 9 days after meningitis induction) or a placebo. Six hours after meningitis induction, the rats that received one dose were killed and the hippocampus and frontal cortex were obtained to assess cytokines/chemokine and brain-derived neurotrophic factor levels. On the 10th day, the rats were submitted to the inhibitory avoidance task. After the task, the animals were killed and samples from the hippocampus and frontal cortex were obtained. The extended administration of cannabidiol at different doses reduced the TNF-alpha level in frontal cortex. Prolonged treatment with canabidiol, 10 mg/kg, prevented memory impairment in rats with pneumococcal meningitis. Although descriptive, our results demonstrate that cannabidiol has anti-inflammatory effects in pneumococcal meningitis and prevents cognitive sequel. (C) 2012 Elsevier B.V. All rights reserved.